A digital therapeutic for proactive monitoring of patients on immune checkpoint inhibitor therapy for early detection of immune-related adverse events

被引：0
|
作者：
Singhal, Shyamali Mallick
Dormady, Shane
Li, Jiali
Singhal, Shiva
Chin, Lynda
机构：
[1] El Camino Hosp, Mountain View, CA USA
[2] Apr Hlth LLC, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
101
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy
    Asher, Nethanel
    Bar-Hai, Neta
    Ben-Betzalel, Guy
    Stoff, Ronen
    Grynberg, Shirly
    Schachter, Jacob
    Frommer-Shapira, Ronnie
    MELANOMA RESEARCH, 2024, 34 (05) : 439 - 449
  • [42] Clinical guideline highlights for the hospitalist: Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy
    Chitnis, Saurabh D.
    Mortazavi, Amir
    JOURNAL OF HOSPITAL MEDICINE, 2023, 18 (11) : 1013 - 1016
  • [43] Immune-related adverse events in patients with pre-existing autoimmune rheumatologic disease on immune checkpoint inhibitor therapy
    Amanda Lusa
    Carolina Alvarez
    Shruti Saxena Beem
    Todd A. Schwartz
    Rumey Ishizawar
    BMC Rheumatology, 6
  • [44] Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
    Reschke, Robin
    Gussek, Philipp
    Boldt, Andreas
    Sack, Ulrich
    Koehl, Ulrike
    Lordick, Florian
    Gora, Thomas
    Kreuz, Markus
    Reiche, Kristin
    Simon, Jan-Christoph
    Ziemer, Mirjana
    Kunz, Manfred
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [45] Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy
    Ekinci, Ferhat
    Balcik, Onur Yazdan
    Demir, Bilgin
    Gursoy, Pinar
    Ozveren, Ahmet
    Erdogan, Atike Pinar
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (08): : 996 - 1003
  • [46] Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor
    Hamada, Kazuyuki
    Isobe, Junya
    Hattori, Kouya
    Hosonuma, Masahiro
    Baba, Yuta
    Murayama, Masakazu
    Narikawa, Yoichiro
    Toyoda, Hitoshi
    Funayama, Eiji
    Tajima, Kohei
    Shida, Midori
    Hirasawa, Yuya
    Tsurui, Toshiaki
    Ariizumi, Hirotsugu
    Ishiguro, Tomoyuki
    Suzuki, Risako
    Ohkuma, Ryotaro
    Kubota, Yutaro
    Sambe, Takehiko
    Tsuji, Mayumi
    Wada, Satoshi
    Kiuchi, Yuji
    Kobayashi, Shinichi
    Kuramasu, Atsuo
    Horiike, Atsushi
    Kim, Yun-Gi
    Tsunoda, Takuya
    Yoshimura, Kiyoshi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
    Koji Haratani
    Hidetoshi Hayashi
    Kazuhiko Nakagawa
    BMC Medicine, 18
  • [48] Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge Reply
    Dolladille, Charles
    Da-Silva, Angelique
    Alexandre, Joachim
    JAMA ONCOLOGY, 2020, 6 (11) : 1814 - 1815
  • [49] Hypohidrosis as an immune-related adverse event of checkpoint inhibitor therapy
    Kersh, Anna E.
    Schuchter, Lynn M.
    Elenitsas, Rosalie
    Chu, Emily Y.
    IMMUNOTHERAPY, 2020, 12 (13) : 951 - 956
  • [50] Association of immune-related adverse events with immune checkpoint inhibitor efficacy in pancancer.
    Ou, Qiyun
    Yu, Yunfang
    Zhong, Haitao
    Li, Anlin
    Chen, Yongjian
    Zhou, Haiyu
    Zheng, Shaopeng
    Huang, Luyu
    Yao, Herui
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345